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Abstract   
BACKGROUND: Maternal depression complicates a large proportion of pregnancies. Current 
evidence shows numerous harmful effects on the offspring. Reviews, which include depression, 
concluded that stress has harmful effects on the offspring’s outcomes neuro-cognitive 
development, temperament traits and mental disorders.  
OBJECTIVE: This mini review of recent studies, sought to narrow the scope of exposure and 
identify studies specifically assessing prenatal depression and offspring neuropsychiatric 
outcomes.  
STUDY ELIGIBILITY CRITERIA: The review included longitudinal, cohort, cross-sectional, 
clinical, quasi-experimental, epidemiological or intervention study designs published in English 
from 2014-2018. 
PARTICIPANTS: Study populations included mother-child dyads, mother-father-child triads, 
mother-alternative caregiver-child triads and family studies utilizing  sibling comparisons.  
METHODS: We searched PubMED and Web of Science. Study inclusion and data extraction were 
based on standardized templates. The quality of evidence was assessed using the Newcastle-
Ottawa Scale(NOS).  
RESULTS: Thirteen studies examining neuropsychiatric outcomes were included. We judged the 
evidence to be moderate to high quality.  
CONCLUSIONS: Our review supports that maternal prenatal depression is associated with 
neuropsychiatric adversities in children.  
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IMPLICATIONS: Future investigations should unravel the biological underpinnings and target 
timely interventions as early in pregnancy as possible to prevent offspring neuropsychiatric harms. 
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Introduction  
Early life environmental adversities may exert consequences upon developing cells, tissues, and 
organs, their structure and function. These biological alterations may result in phenotypic 
differences between individuals that persist throughout the lifespan – a developmental plasticity 
phenomenon called ‘prenatal programming’(1–4).  
Maternal depression complicates a large proportion of pregnancies with 7.4%-20% of women 
experiencing major or minor depression, dysthymia or clinically significant depressive 
symptomatology  during pregnancy(5). Yet, a large proportion of pregnant women with  depression 
remain undetected(6). This does not merely reflect a lack of systematic screening, but also an 
unwillingness of women to admit experiencing depressive symptoms(7). Nearly half of women 
reported feeling too embarrassed to confess to a healthcare professional that they are not feeling 
well and almost one-third were afraid that if they divulged their feelings, their baby would be taken 
away(7). Many of the rest feared repercussions such as  stigma(7).  
Due to the high prevalence, maternal depression is a major complication of pregnancy and 
childbirth. Strongly predicted by prenatal depression(8), maternal postpartum depression also 
carries adverse consequences for the offspring(9). One systematic review and meta-analysis of 
studies published between 2010-2015, concluded that offspring of women with untreated 
depression during pregnancy were 56% more likely to be born preterm(< 37 gestational weeks) 
and 96% more likely to be born with a low birth weight(< 2.5 kg)(10). Another review of studies 
published up to2015 focused on the effects of maternal untreated pregnancy depression on a series 
of offspring outcomes ranging from birth outcomes and physiological effects to cognitive and 
psychopathological effects(11). While the evidence of the reviewed studies showed a number of 
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harmful effects on the offspring, yet the evidence was controversial, particularly regarding preterm 
birth and low birth weight(11). Pregnancy factors such as maternal age, gestation length, current 
maternal depressive status, pre-pregnancy obesity, gestational diabetes/hypertension, pre-
eclampsia, and substance use during pregnancy, if not properly considered, may inflate the to the 
body of evidence. Yet, another recent review of studies published between 2010-2017  concluded 
that maternal stress in pregnancy, which included  depression,  has harmful effects on the 
offspring’s  neuro-cognitive development, negative affectivity, difficult temperament and mental 
health(2). As it is important to consider the althernative possibilities, numerous reviews explore 
the harmful effects of offspring exposure to pharmacologically treated(e.g. SSRIs) maternal 
prenatal depression(12–15).  
To the best of our knowledge, no reviews have focused specifically on the consequences of 
prenatal depression on offspring neuropsychiatric outcomes. Hence, the objective of this review 
was to assess all recent studies assessing prenatal depression and offspring neuropsychiatric 
outcomes. We evaluate the quality of the evidence of the reviewed studies using the Newcastle-
Ottawa Scale assessment(NOS).  To deepen the discussion, we examine whether potential harmful 
effects of maternal depression on offspring neuropsychiatric outcomes are specific to the 
pregnancy period or explained by postnatal depression and whether a specific window of 
vulnerability exists when the effects of prenatal depression on offspring neuropsychiatric outcomes 
are most detrimental. Furthermore, we briefly explore the potential mechanisms through which 
prenatal depression may exert harmful consequences on offspring neuropsychiatric development. 
Lastly, we highlight treatment methods for prenatal depression, thereby possibly preventing 
offspring neurodevelopmental harm. 
Methods  
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We searched Pubmed/MEDLINE and Web of Science databases for human longitudinal, cohort, 
and cross-sectional studies, published between January 2014 and February 2018 in English, with 
either clinical, quasi-experimental, epidemiological or intervention study designs.  
We included studies focusing on mother-child dyads, mother-father/alternate caregiver-child 
triads. Study criteria included  maternal prenatal depression with any depressive disorder diagnosis 
identified via medical registries, psychiatric interview, or depressive symptoms measured with 
self-report questionnaires. We excluded studies that used antidepressant use as the sole exposure 
measure, reported only on lifetime history of depression, used retrospective self-reports or 
unclearly defined exposure. We excluded studies that used other forms of psychological stress or 
only a combined exposure measure, such as a depression and anxiety mean score. For offspring 
neuropsychiatric outcomes, we considered internalizing and externalizing problems, including 
anxiety, depression, attention, conduct problems, Attention Deficit Hyperactivity 
Disorder(ADHD), autism spectrum disorders and schizophrenia. 
We utilized RevMan5 software to generate the PRISMA flow diagram(16) that describes the study 
selection process(Figure 1). The studies’ characteristics, participant demographics and data were 
systematically collected from each study using a standardized template. 
We assessed risk of bias and the methodological quality in non-randomized, non-intervention, 
observational studies using NOS, a recommended method from the Cochrane Handbook of 
Systematic reviews(17,18).   
Results  
The sensitive search strategy applied produced 5712 articles(1083=Pubmed, 4629=Web of 
Science) for all studies up until February 2018. Refining the results to publications from 2014-
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2018, rendered 766 articles(PubMed, n=135; Web of Science, n=631 for title and abstract review.  
Further hand searching of reference lists and other sources augmented the search findings(n=9). 
We included 13 empirical studies that examined prenatal depression and neuropsychiatric 
outcomes in offspring. See Figure 1 for the PRISMA diagram of inclusion. 
  
Summary of Main Findings  
Refer to Table 1 for a complete list of included studies, study characteristics and main findings, as 
well as each studies covariates.  
A Finnish longitudinal cohort study by Korhonen et al.(21), among 192 mother-child dyads, found 
that prenatal depression was significantly associated with the 16-year-old child’s externalizing 
behavior problems. Notably, in this study population, maternal depression, when the child was 8-
9-years-old, was not significantly associated with the child’s behavior problems, but when 
measured at the child’s age of 16 years it was associated with the child’s externalizing behavior 
problems(19). The study reported that children of women who had a ‘high stable’ trajectory of 
depressive symptoms from pregnancy to the child’s adolescence had the highest risk for 
externalizing problems, suggesting that both pre-and-postnatal depression increase the child’s 
risk(19).  
The Finnish Prediction and Prevention of Preeclampsia and Intrauterine Growth Restriction 
(PREDO) study by Lahti et al.(15)  of 2296 mother-child dyads found that higher maternal  
prenatal depressive symptoms  were associated with higher internalizing, externalizing and total 
psychiatric problems of the child aged 1.9-5.9 years. These effects were independent of maternal 
depressive symptoms measured at the childhood follow-up, suggesting that the harmful effects on 
the child outcomes are specific to the prenatal period. The effects were gestation-week non-
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specific, meaning that higher maternal depressive symptoms at the 14 biweekly measurements 
between 12-39 gestational weeks, were associated with more  problems  across a broad range of 
child behaviors(20). The study found that maternal depressive symptoms at the child follow-up 
partially mediated the prenatal depression effects. Additionally, the offspring of women who were 
consistently more depressed during pregnancy and at the childhood follow-up displayed the most 
problems(20), supporting the concept that both pre-  and postnatal factors play a role. 
In another study from the Finnish PREDO cohort by Wolford et al.(18), among 1779 mother-child 
dyads, higher maternal depressive symptoms during pregnancy were  associated with significantly 
increased ADHD symptoms in children aged 3-6 years. These effects were independent of and 
partially mediated by maternal depressive symptoms measured in the childhood follow-up and 
were gestation-week non-specific; children of mothers with consistently high depressive 
symptoms both during pregnancy and in early childhood had the most ADHD symptoms (18). 
The German Franconian Cognition and Emotion Study(FRANCES)  study by Eicheler et al., which 
assessed children of 61 depressed and 143 non-depressed mothers, found that at age 6-9 years, 
offspring of depressed mothers scored higher on anxiety, depression and antisocial behavior(21). 
The associations with child depression and anxiety were independent of maternal depressive 
symptoms measured at the child follow-up, pointing to prenatal specificity of these effects(21). 
Yet, it remains unknown if the prenatal depression effects on child antisocial behavior would have 
been explained by maternal depressive symptoms during the child follow-up as the authors did not 
report these effects in the paper. This study also was unable to address if there would be a 
vulnerability window when maternal depressive symptoms  would have had the most harmful 
offspring consequences, as the study measured  depressive symptoms only once, during the third 
pregnancy trimester(21).    
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 In the Dutch Generation R study by El Marroun et al., among 5596 mother-child dyads,  1.5-6-
year-old children exposed to maternal depressive symptoms (without SSRIs) at 20 weeks of 
gestation showed more pervasive developmental problems than the control group(22). These 
associations remained significant after adjusting for maternal postnatal depression. Supplemental 
analysis indicated that prenatal depressive symptoms tended to be associated with autistic traits 
even after adjusted for maternal  depression at the child’s age of 3 years(23) . This study also 
measured affective problems and found an increased risk for affective problems in children who 
were exposed to prenatal maternal depression (without SSRIs)(23). With only one measure of 
prenatal depression, this study, however, leaves the vulnerability window unclear.  
In the UK  Avon Longitudinal Study of Parents and Children (ALSPAC) by Capron et al. among 
4303 mother-child dyads, higher maternal depressive symptoms at 18th gestational week  were 
associated with and increased risk for anxiety disorder in the 18-year-old offspring(25).   
In another ALSPAC study by Leis et al. among 2891 mother-child dyads, higher maternal 
depressive symptoms  at 18th  and/or 32nd   gestational weeks were associated with higher risk of 
hyperactivity, emotional symptoms, conduct problems and total difficulties in the 11-year-old 
offspring (26).  When the child problems were rated by the child’s teacher, maternal prenatal 
depressive symptoms remained a significant predictor of the child’s hyperactivity(24).  
In the third ALSPAC study by O’Donnell et al. among 7944 mother-child dyads, maternal 
depressive symptoms at 18 weeks gestation predicted consistently elevated levels of the child’s 
behavior problems through ages 4 to 14 years(25).  
All the ALSPAC study findings were independent of maternal postnatal depressive symptoms 
measured at the childhood follow-ups.  While the ALSPAC study has maternal depressive 
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symptoms measurements at 18th and 32nd gestational weeks, these are not systematically reported 
in the studies, hence leaving open the question of a window of vulnerability.  
In another UK study by Plant et al., in the South London Child Development(SLCD) study of 103 
mother-child dyads  maternal depressive symptoms at 20 or 30 weeks of gestation were associated 
with an increased risk of depression in the 25-year-old offspring (26). In this study maternal 
prenatal depressive symptoms were correlated with maternal postnatal depressive symptoms 
measured up to 12 months after delivery. Yet, the postnatal depressive symptoms were not 
associated with the adult offspring depression. In contrast, children exposed to maternal depression 
in early childhood(1-6years) were at an increased risk for adult depression(26). This study also 
revealed an additive effect where each additional exposure to maternal depression measured at 
different developmental stages increased the risk of depressive symptoms in the offspring in 
adulthood(26). This study concluded that childhood maltreatment mediated the effect of maternal 
prenatal depressive symptoms on the child’s adulthood depression(28).  
In another US longitudinal study of 196 young, low income, African American mothers and their 
children, a path analysis indicated two indirect paths mediating the effects of maternal prenatal 
depression on toddler total behavior problems(27). One indirect path indicated a significant path 
of maternal prenatal depression on toddler total problems at 24 months via maternal sensitivity at 
24 months(27). The other indirect path showed that  maternal  depressive symptoms at 24 months 
mediated the effect of maternal prenatal depression on toddler total behavior problems at 24 
months(27). It is unclear from this study whether prenatal depressive symptoms had effects on 
toddler behavior problems that were independent of maternal sensitivity and concurrent 
depression. As this study measured maternal depressive symptoms only once during pregnancy, 
the  study was not able to address the question of specific vulnerability window(27).  
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In another US study by Johnson, in a clinical subsample of 178 depressed mothers from the Emory 
Women’s Mental Health Program for perinatal mental illness, 2.5-5-year-old children exposed to 
maternal pregnancy depression (without SSRI) were  less likely to score in the ‘at-risk range’ for 
pervasive developmental disorder than those exposed to SSRI(28). The post hoc nested sibling 
analysis found that the decreased likelihood for pervasive developmental disorder in children with 
depressed mothers without SSRIs to compared to those with SSRIs  remained significant(28).  
The US Californian registry study by Wieckowski et al., comprising nearly 9 million mother-child 
dyads, found that maternal major depressive disorder(MDD; recurrent and single episode), 
dysthymia, depressive disorder not otherwise specified, and bipolar disorder increased the 4-21-
year-old offspring’s risk of autism spectrum disorder by 1.6-2.75-fold(21). While the timing of the 
maternal hospitalizations during pregnancy and at delivery were available, the study did not report 
the associations separately by trimesters or delivery; nor reported data on maternal hospitalizations 
during the child follow-up period. Hence, it remains unclear if the effects were specific to the 
prenatal period and if effects varied according to pregnancy trimester. 
Quality of the evidence  
We found the overall quality of the evidence as high to moderate based on the NOS Assessment, 
which judged cohort and case-control studies on three domains; 1)selection, 2)comparability, and 
3)outcome(Table 2 & Table 1).   
The 13 prospective studies included in this review represent participants from 6 high income 
countries, 5 of which are European. The ALSPAC(n=3)(1,24,29) and SLCD studies(n=1)(26) both 
drew their cohorts from the southern UK population at around the same time-period. The 
PREDO(n=2)(20,30), MoBA(n=1)(31) and Korhonen et al.(n=1)(19)studies examined Nordic 
populations. The German FRANCES(21) and the Dutch Generation R study(22) both examined 
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southern European populations with Generation R comprising a multi-ethnic European population.  
In the US studies(n=3)(27,28,32), however, the populations’ distinct geographic, socioeconomic 
and clinical characteristics and ethnic variation, separate these three studies from each other. 
All of the studies used mother-child dyads(n=14), however, some studies used an additional 
caregiver measure(i.e. teacher or father)(n=3)(22,24,29), or a sibling comparison model 
(n=2)(28,31). Non-exposed participants were all drawn from the same populations as the exposed 
participants(1,19–22,24,26–32). Notably. there was one clinical subsample study(28). Only two 
studies used an objective maternal depression exposure measure, i.e medical records 
diagnosis(32)and the Clinical Interview Schedule (CIS) structured interview(26). Nine of the other 
studies used validated maternal report measures such as the Center for Epidemiological Studies 
Depression Scale(CES-D)(20,27,30), Edinburgh Postnatal Depression Scale(EPDS) (19,21) for 
measuring prenatal depressive symptoms. The bi-weekly CES-D measurements in the PREDO on 
maternal prenatal depression sets a gold standard for understanding the stability and trajectory of 
symptoms throughout gestation and allows for time point vulnerability exploration(20,30), a key 
tenant missing from the other studies in this review. The ALSPAC study also measured maternal 
depression at multiple prenatal and postnatal timepoints with the EPDS, however, only selective 
timepoints were used in each of the studies’ analyses(24–26,29). The clinical subsample from the 
Emory Women’s Mental Health Program measured exposure using self-reports of SRI use and the 
Beck Depression Inventory, 2nd Edition (BDI-II)(28). Although the BDI-II is a commonly used 
measure for depression in the general population, findings suggest questionable validity in prenatal 
and postnatal samples, especially when compared to the EPDS(33,34). The Norwegian MoBa 
study(31) used 3 selected items from the Symptoms Checklist(SCL) version 5 comprising an 
externally non-validated measure of maternal depressive symptoms(31). Internally, a Norwegian 
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study reporting on the reliability and validity of the short form the psychometric measures used in 
the MoBA study, indicates a strong correlation between the 5 items in the SCL-8 short form and 
in 3 items in the SCL-5 with the original SCL-25 for depression(35). Authors, cited their previous 
work reporting a moderate level of agreement between the self-report and diagnostic interview 
measures, however using the 5-item version of the SCL-5(36).  
For comparability, ten studies controlled for the sex of the offspring as the most important 
confounder(20–22,24–28,30,31), while three studies(19,29,32) did not control for sex, reducing 
comparability. All 13 studies controlled for at least one other important factor such as age, 
gestation length, current maternal depressive status, maternal pre-pregnancy obesity, gestational 
diabetes/hypertension, pre-eclampsia, smoking and alcohol use during pregnancy all of which may 
significantly impact the findings(See Table 1 for all covariates used in each analysis). Although 
one study, did not report any of the adjusted analysis in the paper, as the author's indicated that it 
had no effect on the results(21).  Select studies accounted for novel confounders such as childhood 
maltreatment in path analysis which significantly attenuated the results(26),  paternal pre and 
postnatal depression or sibling analysis(28,31), both of which account for genetic and 
environmental effects supporting the prenatal programming hypothesis. Yet, regarding the sibling 
analyses, maternal depressive symptoms show high continuity from pregnancy to 
postpartum(16,27), and the Gjerde MoBA  study(19) did not describe the level of differential 
exposure among siblings or the inter-correlations between antenatal and postpartum symptoms 
that would have been needed to assess whether multi-collinearity posed a concern for any analyses. 
Overall differences in adjustment for confounders decreased the comparability of the results across 
studies(19–22,24–32).  
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Regarding outcomes, 3 studies used an objective neuropsychiatric outcome measure removing the 
subjectivity of parental report questionnaires via medical records diagnosis (32), the Clinical 
Interview Schedule-Revised (CIS-R)(29) validated in young adult populations for identifying 
anxiety and depression (37), and the Structured Clinical Interview (26).   All other studies (n=10) 
used mother/father/caregiver-rated questionnaires. Six studies used the Child Behavior 
Checklist(CBCL), which measures internalizing, externalizing and total problems, emotionally 
reactive, anxious/depressed, somatic, withdrawn, sleep, attention and aggressive behavior 
problems, and affective, anxiety, pervasive developmental, attention deficit/hyperactivity, and 
oppositional defiant problems alone(19,20,22,23,28,31) or in combination with the Youth Self 
Report(YSR)(19), or the Social Responsiveness Scale(22). Other studies measured parental 
reported symptoms using the Conners’ Hyperactivity Index for ADHD(30), the Brief Infant-
Toddler Social and Emotional Assessment (BITSEA), which assesses internalizing, externalizing, 
dysregulation and competence(27,38) and the SDQ for assessing prosocial behavior, hyperactivity, 
emotional symptoms, conduct problems, peer problems, and total difficulties(1,39). The 
FRANCES study measured internalizing and externalizing behaviors using a psychologist 
administered set of mother-rated questionnaires from the ICD-10 and DSM-IV which are not well-
known and are available only in the German language; hence it remains challenging to evaluate 
their reliability and validity(21) . 
All 13 studies followed participants for a suitable length of time for the designated outcome of 
interest. Notably, however, the CBCL has only been validated for ages 1-5, and inclusion of some 
participants at age 6 could have impacted the results in the Generation R study (40% age 6)(22). 
Nine studies retained adequate numbers for follow-up and clarified how the authors dealt with 
missing data(19–22,26–28,30,31). Originally a very large cohort, the long term follow up of the 
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ALSPAC studies(n=3)(1,24,29) experienced a high attrition rate, especially by follow up at 18 
years(24,25,29). However, the long-term adulthood follow-up in the ALSPAC studies(24,25,29) 
and the US register study(32)is a valuable addition to the literature. Notably, although the majority 
of studies have sample sizes in the thousands(20,22,24,25,29–31), one even over 8,000,000(32)  
five studies in this review have relatively small sample sizes(19,21,26–28).  
Limitations for this review as a whole, include the small number of studies which met the inclusion 
criteria and a high risk of publication bias across the included studies. Furthermore, our data 
extraction was performed by only one author. One question pinpointed at the beginning of this 
review, e.g. a specific gestational vulnerability timepoint, could not be fully elucidated based on 
the current body of evidence and the lack of replication multi-point measures across studies. 
Discussion 
This review of 13 studies supports the previous findings reviewed by Van den Bergh et al.(2017), 
suggesting that prenatal depression is associated with adverse neuropsychiatric consequences on 
the offspring. Ten studies(19,20,22,24–30) favored the conclusion that the effects of maternal 
depression on offspring neuropsychiatric outcomes are specific to the maternal pregnancy period 
and are not accounted for by depression after pregnancy. Two studies(21,32), however, did not 
address the pre vs postnatal specificity question, and another(31) concluded that the offspring 
neuropsychiatric effects are not specific to the prenatal period, but are rather a consequence of 
maternal depression during the offspring postnatal development. As discussed previously, the one 
dissenting study used non-validated measures of maternal depression, which hampers it’s 
reliability(31).  Importantly, maternal depression shows high continuity from pregnancy onwards, 
with study populations(20,30) indicating that in over 50% of the women, clinically relevant 
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depressive symptomatology during pregnancy persists after delivery. Therefore, the question of 
exposure timing during pregnancy or after delivery of the maternal effects may be difficult to 
disentangle because of statistical multi-collinearity problems. Only the PREDO cohort from this 
review, with 14 by-weekly gestational measurements of maternal depressive symptoms was able 
to address the question of a specific vulnerability window, which showed that the effects on child 
problem behaviors were gestation week non-specific(20,30). 
Pathways 
Prenatal depressive symptoms may influence child neuropsychiatric outcomes via multiple 
psychological, health behavior, and biological pathways. An important component of 
understanding theses pathways, involves disentangling the effects of other pregnancy and perinatal 
complications, which may contribute to the severity, duration, and complexity of maternal prenatal 
depression. For instance, recent meta-analyses and systematic reviews show that maternal obesity 
in early pregnancy is associated with an increased risk of depression during pregnancy(40,41). 
Also in the PREDO cohort, from a study not in this review, women with early pregnancy 
overweight and obesity had consistently elevated depressive symptoms throughout pregnancy and 
after delivery(8).  Evidence suggests that gestational diabetes and hypertension spectrum disorders 
may also be associated with prenatal depression(42), but these findings remain controversial(8). 
Maternal cardio-metabolic conditions might contribute as one of the pathways, as a meta-analysis 
found that maternal obesity predicted an increased risk of autism and ADHD, developmental delay 
and emotional/behavioral problems in children(43). Also, we  recently showed that maternal 
severe obesity in early pregnancy is associated with hyperactivity, sleep problems, conduct, 
externalizing and total problems, depressive symptoms, anxiety and ADHD problems in 
children(44). Gestational diabetes has repeatedly been associated with an increased risk of 
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neuropsychiatric disorders, particularly of autism and schizophrenia in the offspring(45–48). Yet, 
in the PREDO maternal obesity or gestational diabetes were not associated with mother-rated 
internalizing, externalizing or total psychiatric problems in 1.9-5.9-year-old children (20), but were 
associated with child neurodevelopmental delay(49).  
Prenatal depression also increases risks of preterm birth and low birth weight(42,50). Also in the 
PREDO cohort, maternal depressive symptoms during pregnancy predicted shorter gestation 
length(51). Preterm birth and low birth weight have been consistently shown to be risk factors for 
neuropsychiatric disorders(52–56), and in sibling comparisons(53,54). 
Evidence from a meta-analysis and from large population-based studies suggests that depressed 
mothers are more likely to smoke throughout pregnancy(42,57), and prenatal smoking has been 
repeatedly associated with the risk of neuropsychiatric disorders in the offspring(20,58,59). Also 
in the PREDO, prenatal smoking was associated with increased internalizing, externalizing total 
psychiatric and ADHD problems in children(20,30). 
Biological Mechanisms 
The biological mechanisms possibly linking maternal depression and psychological distress more 
generally with offspring neuropsychiatric outcomes were reviewed in Van den Bergh et 
al.(2017)(2). According to this review, and studies published since, prenatal depression may be 
associated with child neurodevelopment via 1)alterations in hypothalamus-pituitary-
adrenal(HPA)-axis functioning, 2) functional and structural changes of related brain areas 
including amygdala and prefrontal cortex, 3)changes in autonomic nervous system and 4) immune 
system functioning and in gut microbiota(2,60,61). 
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At population level, one of the most consistent biological changes in depression is altered cortisol 
levels, indicating altered HPA-axis functioning(2,62,63). However, studies linking maternal 
depression specifically during pregnancy with maternal or infant cortisol levels have yielded 
inconsistent findings(2,62,63). Yet, maternal HPA axis functioning during pregnancy has been 
linked with offspring neuropsychiatric problems(2). For instance, we recently showed that 
maternal licorice consumption during pregnancy predicted an over 3-fold risk of ADHD problems 
in the offspring(64) due to Glycyrrhizin, which inhibits the placental 11β-hydroxysteroid 
dehydrogenase type 2(11βHSD2) enzyme. This enzyme protects the fetus from maternal 
glucocorticoids, hence leaving the fetus vulnerable to maternal glucocorticoid excess. 
Furthermore, structural and functional changes in the infant amygdala, which regulates HPA axis 
functioning, have been repeatedly reported as a consequence of prenatal depression(2,65–67) and 
are also associated with child psychopathology risk(68,69). Also, alterations in the functioning of 
the autonomic nervous system that also plays a key role in the stress response have been found in 
children exposed to prenatal depression(2).  
Changes in inflammatory pathways and gut microbiota, as a consequence of prenatal depression, 
offer another route through which prenatal depression may affect child neuropsychiatric problems. 
Maternal prenatal cytokine levels present questions for epigenetic programming as cytokines may 
pass through the placenta(70).  Higher prenatal depression has also been directly associated with 
maternal inflammatory cytokine levels during pregnancy(71,72), but the findings are inconsistent. 
Correspondingly both anti-inflammatory drugs(73) and probiotics(74) have antidepressant effects. 
Prenatal levels of C-reactive protein(CRP), a key inflammatory marker, have been associated with 
offspring risk of different neuropsychiatric disorders (75–78), and prenatal depression is associated 
with offspring CRP levels(79).  Evidence for the gut microbiota pathway predominately stems 
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from animal studies but two recent studies have shown microbiota changes in offspring exposed 
to prenatal depression(80,81). Nonetheless, the biological mechanisms involved warrant further 
research.   
Cellularly, depression-related changes in fetal biology studies have specifically focused on 
epigenetic modifications. There are several recent systematic reviews on the effects of maternal 
psychological distress during pregnancy and more specifically antenatal depression on placental 
and infant DNA methylation(2,82,83). Overall, these reviews state that the findings are 
inconsistent but many candidate gene studies have linked methylation of the NR3C1, the 
glucocorticoid-receptor gene, with maternal prenatal depression. Other potential, often examined, 
candidate genes include 11BHSD2, FKBP5, IGF2, SLC6A4, OXTR, CRH and BDNF, genes that 
also play roles in HPA axis regulation. Most studies have focused on either assessing placental 
DNA methylation or infant cord-blood methylation levels. The studies have identified some 
significant effects, which still need validation. Future larger epigenome-wide-association studies 
harmonizing and pooling data into meta-analyses will overcome the current single study 
limitations.  
Recent findings from the PREDO suggest that changes in placental gene expression and infant 
DNA cord blood methylation as well as morphological changes in placental structure may be 
among the mediating biological pathways between antenatal depressive symptoms and child 
psychiatric problems. Among approximately 60 PREDO participants, prenatal depressive 
symptoms were associated with higher placental mRNA levels of glucocorticoid and 
mineralocorticoid receptor genes. Findings which suggest higher placental glucocorticoid 
sensitivity (84,85). In a UK longitudinal study among 93 participants, we found that higher 
prenatal depressive symptoms were associated with reduced placental IGF2-2 mRNA levels and, 
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particularly in the placentas of female fetuses, with altered mRNA levels of several genes 
regulating fetal glucocorticoid exposure(86).  Furthermore, among PREDO participants, maternal 
prenatal depressive symptoms were associated with lower infant epigenetic gestational age at birth, 
a biomarker of the developmental maturation level of the fetus. This biomarker predicted increased 
total and internalizing psychiatric problems in  boys, and partially mediated the effects of maternal 
prenatal depression on boys’ internalizing problems(87). Another PREDO study assessing 
placental morphology among 86 participants found less variation in placental villous barrier 
thickness of gamma-smooth muscle actin-negative villi in the placentas of antenatally depressed 
mothers, indicating reduced placental maturation, due to prenatal depression. This placental 
structural change predicted internalizing and total psychiatric problems in 60 toddlers(88).   
Treatments of prenatal depression 
Predictors for full recovery from prenatal depression include the absence of maternal health 
concerns, low total parental stress status, and limited child behavior issues(89), while maternal 
sensitivity has been found to attenuate the effects of maternal prenatal depression on toddler total 
problems (27), all which underscore the need for a comprehensive treatment approach for prenatal 
depression. Antidepressant medication may offer an option as several reviews indicate the 
likelihood of serious harms is low (12–15). Although,  investigations into specific medications and 
classes of anti-depressants (90–92) complicate the literature, suggesting serious harmful effects, 
leading many doctors not to prescribe and/or many women refuse/discontinue medication in 
pregnancy(5).  Until the data on the safety and efficacy of antidepressant therapies is clearly 
defined, efforts should be concentrated to assess alternative therapies. Although, they stray from 
antidepressants, pregnant women have reported an interest in cognitive behavioral therapy(5), 
which recent review evidence suggests has robust effects for the treatment of women with 
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MDD(93). However, due to a lack of resources and limited access to standard therapies: nearly 
half of diagnosed women fail to receive timely evidence-based treatment(94).  In lieu of standard 
delivery, online cognitive behavioral therapy interventions may serve as an effective measure for 
improving maternal perinatal mental health(95,96). Recent studies have considered the 
effectiveness of  relaxation practices through musical therapy(97), fish oil supplementation (98), 
dietary supplementation(99) and future studies could consider probiotics supplements.  
Conclusions  
Our review found a limited amount of high to moderate quality evidence supporting the association 
of prenatal depression and neuropsychiatric outcomes in children, published 2014-2018. More, 
carefully conducted cohort studies with multi-time point, validated exposure and outcome 
measures investigating epigenetic and protective factors are needed to further corroborate the 
findings relating to a specific developmental vulnerability period. Further investigations into the 
implications of the timing and consistency of exposure, confounding by other perinatal conditions, 
and possible biological mechanisms would bolster the evidence. Future research needs continuous 
and prospective measures of maternal depressive symptoms throughout pregnancy and beyond, in 
order to better scope the prenatal and postnatal trajectories of depression, risk factors, and include 
follow-up of offspring into adulthood to assess long-term neuropsychiatric effects.  
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Figure 1. PRISMA Flow Diagram: Study inclusion and exclusion process 
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Table 1: Summary of Included Study Characteristics & Main Findings 
Study Source Population 
Sample 
Size Study Design 
Maternal Exposure  
Measurement  
  Offspring Outcomes 
Measurements  
Results  
Statistical Analysis 
FINLAND         
Korhonen et al. 
2014 
Finnish 
longitudinal 
cohort study 
Finnish mother-child 
dyads 
192 cohort 
Prenatal: EPDS4  in the last 
trimester 
 
Postnatal: EPDS4   2 weeks, 2 
months, 6 months, 4-5 years, 
8-9 years & 16-17 years 
 
CBCL1 & 
YSR11 at multiple times up 
to age 16 
 
Time of the initial exposure for  maternal depressive symptoms and  adolescent CBCL/YSR outcomes were 
significant for the following: 
Initial Prenatal (Last trimester) exposure & externalizing problems: P=0.037, standard effect size 0.40 (CBCL) 
   P=0.092. standard effect size 0.30 (YSR) 
Initial Postnatal (2 months) exposure & internalizing problems: P=0.030, standard effect size 0.90 (YSR) 
Initial Postnatal (16 years) exposure & externalizing problems: P=0.003, standard effect size 1.00 (YSR) 
Adjusted Covariates: Int.Epis.Time 
Lahti et al 
2017 
PREDO1 Finnish, mother-child 
dyads 
2296 cohort 
Prenatal: CES-D Bi-weekly 
between weeks+days 
12+0/13+6 and 38+0/39+6 
or delivery.  
Postnatal: Becks Depression 
Inventory 1½−5 years 
 CBCL
6 at  ages 1.9-5.9-
years 
Maternal depressive symptoms during pregnancy predicted significantly  
higher internalizing (0.28 SD unit per SD unit increase  
[95% CI = 0.24, 0.32]), externalizing (0.26 [0.23, 0.30]), and  
total problems (0.31 [0.27, 0.35]) in children.  
Adjusted Covariates:  Hist.Dep, Antidep., Psycho.Meds, SDP, Par., PPH, M.Diab., Sex, GL, BWT, Fam.Stat., ADP, M.Edu, 
CA  
Wolford et al 
2017 
PREDO Finnish, mother-child 
dyads 
1779 cohort 
Prenatal: CES-D Bi-weekly 
between weeks+days 
12+0/13+6 and 38+0/39+6 
or delivery.  
 
Postnatal: Becks Depression 
Inventory 1½−5 years 
 CHI questions (ADHD) at 
3-6 years old 
Children of mothers with consistently high prenatal depressive symptoms showed higher average levels  
(MD = 0.46 SD units, 95% CI 0.36, 0.56, p < 0.001 compared to the low group), 
 and proportion (32.1% vs. 14.7%) and odds (OR = 2.80, 95% CI 2.20, 3.57, p < 0.001) of clinically significant 
ADHD symptoms. 
Adjusted Covariates: M.ADHD, Hist.Dep, Antidep., psycho.meds, SDP, pari., PPH, M.Diab., Sex, GL, BWT, Fam.Stat., 
ADP,, M.Edu, CA  
NORWAY         
Gjerde 2017 MoBA 11,599 Norwegian 
families  
17830 
siblings  
cohort 
 Prenatal: SCL-90 Short 
form SCL-5 and SCL-8 self-
rating questionnaires 
 17th week & 30th week 
gestation 
Postnatal: 6 months, 18 
months, 3 years & 5 years 
after birth 
 
 CBCL6 at 1.5, 3 and 5-years 
In sibling comparison, concurrent maternal depression was significantly  
associated with internalizing [estimate = 2.82(1.91, 3.73, 95% CI)] 
 and externalizing problems [estimate = 2.40(1.56, 3.23, 95% CI)] 
Adjusted Covariates: CA, Sex, Par., M.Edu 
GERMANY         
Eichler et al 
2017 FRANCES 
German, mother-child 
dyads randomly selected 
from the FRAMES 
study population   
204 case-control 
Prenatal: EPDS  3rd 
trimester 
Postnatal: EPDS 6-9 years 
 
 
Parental Questionnaire 
from ICD-10 and DSM-IV 
aged 6-9 
Total Sample: 6.74(4.95) , Mother not depressed: 4.04(2.59), 
Mother depressed: 13.07(3.01) 
Not-depressed vs. depressed: −21.7** P-value: 0.000 
Adjusted Covariates: Sex, Fam.Stat., CMD 
THE NETHERLANDS        
El Marroun et 
al. 2014 
Generation R 
Dutch mothers-child 
dyads & father-child 
dyads 
5976 Cohort 
Prenatal SSRI Exposure: 1) 
SSRI use self-report, 2) 
pharmacy prescription 
records 
 
Prenatal Depression 
Exposure: BSI12  at 20 weeks 
gestation 
 
 
CBCL &  
SRS13 at ages 1.5, 3 and 6 
years 
Maternal depressive symptoms (without SSRIs) associated with mother rated child affective problems 
(OR=1.44, 95%CI 1.15, 1.81, P=0.001).  
Maternal depressive symptoms (without SSRIs) and Father ratings of child affective problems were also 
significant (OR=1.60, 95% CI 1.05, 2.45, P=0.03) 
Prenatal depressive symptoms as a continuous variable were also associated with affective problems (OR= 
1.35, 95% CI 1.13, 1.61, P=0.001). 
Maternal prenatal depressive symptoms (without SSRIs) exposed children had more pervasive developmental 
problems in clinical range (OR=2.02, 95% CI 1.53, 2.66). 
Maternal prenatal depressive symptoms (without SSRIs) exposed children after adjusting for depression at age 
3 had more pervasive developmental problems. (OR=1.44, 95%CI 1.07, 1.93, p=0.02) 
Maternal prenatal depressive symptoms were associated with autistic traits (β=0.05, 95% CI 0.01, 0.08, 
P=0.001) 
Maternal prenatal depressive symptoms (continuous) associated with autistic traits (β=0.05, 95% CI 0.03, 
0.07).  
Direct comparison of the effect estimates of SSRI use and depression symptoms without SSRI use (β=0.09, 
95% CI 0.01, 0.17) 
Adjusted Covariates: MA, Sex, M.Edu, ethnicity, SDP, GA,CMD 
UNITED KINGDOM        
Capron 2014 ALSPAC14 
Avon region, UK 
Mother-Father-Child 
triads 
4303 Cohort 
Prenatal: EPDS4  at 18 weeks 
gestation 
Postnatal: EPDS4 8 weeks & 
21 months  
 CIS-R16 at age 18 years  
 
Children exposed to maternal prenatal depression at 18 weeks had increased risk of anxiety at age 18: 
 (Adjusted for postnatal depression at 8wks) OR=1.75 (95% CI 1.19, 2.58)* 
(Adjusted for postnatal depression at 21 months) OR=1.62 (95% CI 1.06, 2.47)* 
The risk from paternal prenatal depression at 18 weeks was not significant. 
Adjusted Covariates: MA, BWT, Par., ACDP, SDP, M.Edu, PNDA 
 
 
Leis et al 2014 ALSPAC14 
Avon region, UK 
Mother-Teacher-Child 
triads 
2891 Cohort 
Prenatal: EPDS4 at 18 & 32 
weeks gestation  
 
Postnatal: EPDS4 at 8 weeks, 
8, 21, 33, 61 & 73 months 
 SDQ17 at age 10-11 years 
 
Children exposed to elevated levels of  maternal prenatal depression (>13 EPDS) at one or both of the 
time-points had increased scores (adjusted β (SE)) for: 
(hyperactivity) 0.35(0.13) p <0.01 (also significant for teacher rated SDQ) 
 
(emotional symptoms) 0.24 (0.09) p <0.01  
(conduct problems) 0.20 (0.08) p <0.01 (also significant for teacher rated SDQ) 
(peer problems) 0.21 (0.09) p <0.05 
(total problems) 1.00 (0.27) p <0.001 (also significant for teacher rated SDQ) 
Adjusted Covariates: Psycho.Vari., MA, BWT, Sex, SDP, ADP, M.Edu, Fam.Stat. 
O´Donnell et 
al. 2014 
 
ALSPAC Avon region, UK 
Mother-Child dyads 
7944 Cohort 
Prenatal: EPDS4 18 weeks 
gestation  
Postnatal: EPDS4 at 8 weeks 
& 33 months postpartum 
 SDQ
17 at age 
4, 7, 9, 11.5 & 13 years 
 
Intercept                      Estimate SE Est/SE p 
Maternal prenatal depression (32 weeks) 0.077 0.014 5.597 0.000 
Maternal postnatal depression (8 weeks) 0.127 0.014 9.162 0.000 
Maternal depression at 33 months post. 0.183 0.013 13.776 0.000 
Adjusted Covariates: MA, M.Edu, SES, BWT, GA, Sex, SDP, ADP, CMD, Pater.Anxi., Parent.Index 
Plant et al. 
2015 SLCDS
17 UK mother-child dyads 103 Cohort 
Prenatal: CIS-R16 at 20 & 36 
weeks gestation 
Postnatal:  
CIS-R16 at 3 months & 12 
months  
 
SADS-L18 at 4 years, 11, and 
16 years 
 
 
Structured Clinical 
Interview for DSM-IV Axis 
I Disorders at age 25 
 
Offspring exposed to maternal prenatal depression had an increased risk depressed in adulthood. 
OR=3.4(95% CI 1.15, 8.1) X2(1)=8.4, p=0.004 
Mean number of depressive symptoms was higher for those who were exposed to prenatal depression (M=3.4, 
SD 3.0) 
Than those unexposed (M=1.7, SD 2.(, z=-2.8, p=0.004). 
Maternal depression in the postnatal period up to 1 year was not associated with adult depression: 
OR=1.8, (95% CI 0.8, 4.2) X2(1)=2.1, p=0.15 
Maternal depression in offspring childhood (1-16 years) was associated with depression in adulthood 
OR=4.2 (95% CI 1.8, 10.2) ) X2(1)=11.1, p=0.001 
Maternal prenatal depression effects on offspring adult depression was mediated by childhood maltreatment 
B=0.39, (95% CI 0.04, 1.05) 
Adjusted Covariates: MA, ethnicity, SES, M.Edu, Fam.Stat., Psycho.Vari., His.Dep, SDP, ADP, GA, BWT, Sex, Ethnicity, 
C.Edu, C.IQ  
UNITED STATES OF AMERICA        
Edwards et al. 
2016 
US longitudinal 
study 
Young, low SES, 
African American 
mother-child dyads 
196 Cohort 
Prenatal: CES-D during 
pregnancy  
Postnatal: CES-D at 24 
months 
 BITSEA at age 24 months 
 
Path analysis  
Prenatal Depression maternal Sensitivity  behavior problems  
(Full Sample) B(SE) 0.031 (0.020) 95%  CI (0.003, 0.083)* 
(Boys) B (SE) 0.052 (0.035) 95% CI (0.003, 0.147)* 
(Girls) B (SE) 0.002 (0.015) 95% CI (-0.023, 0.044) 
Prenatal Depression 24 month depression  behavior problems  
(Full Sample) B(SE) 0.086 (0.032) 95% CI (0.027, 0.152)* 
(Boys) B (SE) 0.073 (0.016) 95% CI (0.016, 0.044) * 
(Girls) B (SE)  0.097 (0.061) 95% CI (-0.016, 0.225) 
Adjusted Covariates: Sex, mom-dad 
Johnson 2016 Emory 
Women’s 
Clinical sample of USA 
Mother-child-child 
triads 
178 Clinical, 
observational  
Prenatal: 
BDI7  during pregnancy 
Postnatal: BDI at follow-up 
 CBCL
6 PDD15 in sibling 
pairs at ages 2.5-5 years 
 
Children exposed to prenatal depression (without SRI exposure) less likely to score in the high risk range on the 
PDD than those exposed to SRIs: 
Mental Health 
Program  
 (mother rated): β= -0.163 Unstandardized B coefficient -0.001 (95% CI <-0.001, 0.002, P=0.048)* 
Adjusted Covariates: CA, Sex, MA, Fam.Stat., M.Occup., C.Early Learn., CMD, SDP, ADP, Antidep., Psycho.Meds, BWT, 
HC,Apgar, GA, Deliv.Meth., DelivComp, NumbComp, MDep, MoodEpi., Glob.Funct., M.Epilep.Stat. 
Wieckowski et 
al 2017 
Hospital 
discharge 
records 
California singleton 
births occurring 1/1/91-
12/31/08  
8951763 retrospective 
cohort 
Medical records  ICD-9-CM 
code for Depressive disorder 
NOS 311.x Anytime in the 
prenatal or perinatal period 
 
 
California Dept. Of 
Developmental services 
diagnosis 
(Autism) age 4-21years 
 Mothers diagnosed with one individual psychiatric condition were  
1.2-2.8 times more likely to have a child who developed autism.  
Mothers diagnosed with any one or more psychiatric condition  
were twice as likely to have a child with autism compared with  
unaffected or unreported women (RR = 1.97; 95% CI 1.83, 2.12). 
Adjusted Covariates: M.Origin, MA, M.Edu, Ethnicity 
         
1. Prediction and Prevention of Preeclampsia and Intrauterine Growth Restriction 
2. Center for Epidemiologic Studies Depression Scale 
3. Franconian Cognition and Emotion Studies( Follow-up study to the FRAMES cohort) 
4. Edinburgh Postnatal Depression Scale  
5. Norwegian Mother and Child Cohort study 
6. Child Behavior Checklist  
7. Beck Depression Inventory/ Beck Depression Inventory II 
8. Selective Serotonin Reuptake Inhibitors 
9. Medically untreated depression group 
10. Control group 
11. Youth Self Reports 
12. Brief Symptom Inventory 
13. Social Response Scale 
14. Avon Longitudinal Study of Parents and Children 
15. Pervasive Developmental Disorders (CBCL Subscale) 
16. Clinical Interview Schedule- Revised 
17. South London Child Development Study 
18. Schedule for Affective Disorders and Schizophrenia  
Adjusted Covariates: Antidep. (Antidepressant Use), ACDP (Alcohol Consumption During Pregnancy), 
Apgar(Apgar Score),BWT (Birthweight), CA(Child Age), C.EarlyLearn.(Child Early Learning Center 
attendance), C.Ethnicity (Child ethnicity), C.IQ (Child IQ score) C. Mal.(childhood maltreatment), 
CMD(Concurrent Maternal Depression), Deliv.Meth.(Delivery Method), Deliv.Comp(Delivery Complications),  
Fam.Stat (Family Status),  GA(Gestational Age), GL(gestational length), GDH(Gestational 
Diabetes/Hypertension), Glob.Funct.(Global assessment of Functioning), HC(Head Circumference), 
Hist.Dep(History of Diagnosed Depression) , Int.Epis.Time (Initial episode timing), M.ADHD (Maternal ADHD), 
MA (Maternal Age), MDep(Maternal Prenatal Depressive Symptoms), M.Edu(Maternal Education Status), M. 
Ethnicity (Maternal Ethnicity), M.Occup (Maternal Occupation/Status), M.Epilep.Stat.(Maternal Epileptic Status), 
MoodEpi.(Mood Episodes), Numb.Comp(Number of Pregnancy Complications), Par. (Parity), 
Pater.Anxi.(Paternal pre/postnatal Anxiety), Parent.Index(Parenting Index Score), PE(Pre-Eclampsia, Mom-
dad(mother-father relationship), PD(paternal depression), PND(Postnatal depression), PNDA(Maternal Postnatal 
Depression & Anxiety), PPObes.(Pre-Pregnancy Obesity),  Psycho.Meds.(Psychotropic Medication use), 
Psycho.Vari.(Psychological Variables), SDP(Smoking During Pregnancy)
 
 
Table 2. NOS Quality of Evidence (Table listed in order of source country and then alphabetically.) 
The Newcastle-Ottawa Scale assesses studies on 3 domains: Selection of study participants, Comparability of the studies, and the selection of the Outcomes. A study can receive a maximum of 4 stars in the Selection 
domain, 2 stars in the comparability domain, and 3 stars in the Outcomes domain.  
 
 
Quality 
Assessment 
Criteria 
Selection (⋆⋆⋆⋆) Comparability (⋆⋆) Outcome (⋆⋆⋆) Score 
Representativeness 
of exposed cohort? 
Selection of the 
non-exposed 
cohort? 
Ascertainment of 
exposure? 
Demonstration that 
outcome of interest 
was not present at 
start of study? 
Study 
controls 
for 
sex? 
Study controls for at least one 
additional 
factor? 
Assessment 
of 
outcome? 
Was follow-up long 
enough for outcome 
to occur? 
Adequacy of 
follow-up of 
cohorts? 
Overall 
Quality 
Score 
Acceptable 
(⋆) 
Representative of 
average in 
community  
Drawn from same 
community as 
exposed 
cohort 
Secured records, 
Structured 
interview 
Children not yet born, 
therefore outcome not 
yet possible. 
Yes 
Age, pre-pregnancy obesity, 
gestational length, current 
maternal depression status, 
gestational diabetes/hypertension, 
pre-eclampsia, smoking & alcohol 
use during pregnancy, mother-
father relationship, paternal 
depression, childhood 
maltreatment 
Independent 
blind 
assessment, 
record 
linkage 
Follow-up time 
period sufficient to 
measure outcome 
Complete 
follow-up, or 
subjects lost to 
follow-up 
unlikely to 
introduce bias 
High1 
Moderate2 
Poor3 
Korhonen 
et al. 2014 
⋆ ⋆  ⋆  ⋆  ⋆ ⋆ High 
Lahti et al. 
2017 
⋆ ⋆  ⋆ ⋆ ⋆  ⋆ ⋆ High 
Wolford et 
al. 2017 
⋆ ⋆  ⋆ ⋆ ⋆  ⋆ ⋆ High 
Gjerde  et 
al. 2017 
⋆ ⋆  ⋆ ⋆ ⋆  ⋆ ⋆ High 
Eichler et 
al. 2017 
⋆ ⋆  ⋆ ⋆ ⋆ 
 
 ⋆ ⋆ High 
El Marroun 
et al. 2014 
 
⋆ ⋆  ⋆ ⋆ ⋆ ⋆   Moderate 
Capron  et 
al. 2014 
 
⋆ ⋆  ⋆  
⋆  
 
⋆ ⋆ ⋆ High 
Leis et al. 
2014 
 
⋆ ⋆  ⋆ ⋆ ⋆  ⋆  Moderate 
O’Donnell 
et al. 2014 
 
⋆ ⋆  ⋆ ⋆ ⋆  ⋆  Moderate 
 
 
 
1 High quality: ≥ 7⋆ (Additional requirements: Selection domain 3-4 stars AND Comparability domain 1-2 stars AND Outcome domain 2-3 stars) 
2 Moderate quality: ≥ 5⋆ (Additional requirements:  selection domain 2 stars AND comparability domain 1-2 stars AND outcome domain 1-3 stars) 
3 Poor quality: ≤ 4⋆ (Additional requirements: selection domain 0-1 stars OR comparability domain 0 stars OR outcome domain 0 stars) 
 
Plant et al. 
2015 
⋆ ⋆ ⋆ ⋆ ⋆ ⋆ ⋆ ⋆ ⋆ High 
Edwards et 
al. 2016 
 
⋆ ⋆  ⋆ ⋆ ⋆ 
 
 ⋆ ⋆ High 
Johnson et 
al. 2016 
 
⋆   ⋆ ⋆ ⋆ ⋆ ⋆ ⋆ Moderate 
Wieckowski 
et al 2017 
⋆ ⋆ ⋆ ⋆  ⋆ ⋆ ⋆ ⋆ High 
Review: Depression & Offspring 
Appendix 1 
Search Strategy 
Database: WEB OF SCIENCE 
Results: 572 
(from Web of Science Core Collection) 
Searched for: TOPIC:(maternal OR paternal OR mother) AND TOPIC:(depression OR depressive symptoms OR 
depress*) AND TOPIC:(child OR offpspring OR fetus) AND TOPIC:(pregnancy OR prenatal OR postnatal OR 
antenatal) AND YEAR PUBLISHED:(2017-2018) ...More TOPIC:(maternal OR paternal OR mother) AND 
TOPIC:(depression OR depressive symptoms OR depress*) AND TOPIC:(child OR offpspring OR fetus) AND 
TOPIC:(pregnancy OR prenatal OR postnatal OR antenatal) AND YEAR PUBLISHED:(2014-2018)  
Timespan: All years. Indexes: SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH, BKCI-S, BKCI-SSH, 
ESCI, CCR-EXPANDED, 
 
